Ís
lenska
Search
My pages
Main menu
Close
Medicinal products
Development
Medical Devices
Regulated entities
Pricing and Reimbursement
Published Material
IMA
Medicinal products
About Medicinal products
Medicines in luggage and postal shipments
Marketing Authorisations
Electronic Applications
Package labelling and leaflets
Other Registrations/Authorisations
RMS and National Requests
Text Processing
Withdrawals
Zero Day Procedure
Over the counter (OTC) – guidelines
Processing time for applications
Pharmacovigilance
Report an Adverse Drug Reaction
Educational materials
Quality Standards
Reported Medicine Shortage – Overview
Safety Features of Medicinal Products
Electronic Patient Information
Quality defects and recalls
Development
About Development
Clinical Trials
Substantial Amendments
Notifications and Reports
SUSAR Reporting
Scientific Advice
Medical Devices
About Medical Devices
Clinical investigations
Instructions for use
Use and vigilance of Medical Devices
Registration of distributors
Regulated entities
About Regulated entities
Manufacturers
Medical Centers
Narcotic Drugs and Other Controlled Substances
Controlled Substances
Narcotics
Other Regulated Entities
Pharmacies
Wholesalers and Distributors
Licenses for Import and Wholesale Distribution of Medicinal Products
Pricing and Reimbursement
About Pricing and reimbursement
Icelandic Medicine Price Catalogue
The Exchange Rate of the Icelandic Price Catalogue
Published Material
About Published Material
Annual Reports
Forms
Guidelines
Lists
News
FAQ
IMA
About IMA
Roles and Organization
European cooperation projects
Strategy
Fees
Laws and Regulations
Type your search and press enter
Search here!
Type what you want to find
Greinasafn
December 17, 2021
13. What happens when a product becomes commercially available in Iceland? Does all „compassionate“ supply finish immediately or is there any period to allow a patient to move from a compassionate to a commercial supply of the drug?
December 17, 2021
12. Are there any specific reporting obligations, e.g. pharmacovigilance, adverse event reporting?
December 17, 2021
11. Are there any rules and restrictions for import?
December 17, 2021
10. Are pharmacies able to hold stock of these products?
December 17, 2021
09. Does the product need to be licenced somewhere in the EU?
December 17, 2021
08. How long does the approval last and can it be renewed?
December 17, 2021
07. How long does it take to get an approval?
December 17, 2021
06. Can an application be made for a group of patients?
December 17, 2021
05. Who is responsible for making the request?
December 17, 2021
04. Must the product be provided free of charge?
December 17, 2021
03. Are there special requirements regarding labelling?
December 17, 2021
02. Are there any restrictions?
December 17, 2021
01. How are products prescribed for compassionate use handled in Iceland?
Contact us
How can we help?
Start a chat
Send an email
Request a phone call
LiveChat
Chat with us
, powered by
LiveChat